A detailed history of Pier 88 Investment Partners LLC transactions in Dexcom Inc stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 6,400 shares of DXCM stock, worth $512,256. This represents 0.56% of its overall portfolio holdings.

Number of Shares
6,400
Previous 13,630 53.04%
Holding current value
$512,256
Previous $1.55 Million 72.3%
% of portfolio
0.56%
Previous 1.78%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$64.0 - $116.06 $462,720 - $839,113
-7,230 Reduced 53.04%
6,400 $428,000
Q2 2024

Aug 06, 2024

BUY
$110.31 - $140.45 $432,415 - $550,564
3,920 Added 40.37%
13,630 $1.55 Million
Q1 2024

May 10, 2024

BUY
$114.22 - $140.1 $214,733 - $263,388
1,880 Added 24.01%
9,710 $1.35 Million
Q4 2023

Feb 09, 2024

SELL
$75.49 - $124.16 $372,920 - $613,350
-4,940 Reduced 38.68%
7,830 $971,000
Q3 2023

Nov 09, 2023

SELL
$86.06 - $137.93 $508,614 - $815,166
-5,910 Reduced 31.64%
12,770 $1.19 Million
Q2 2023

Aug 07, 2023

SELL
$112.47 - $130.98 $280,050 - $326,140
-2,490 Reduced 11.76%
18,680 $2.4 Million
Q1 2023

May 09, 2023

BUY
$104.0 - $122.92 $499,200 - $590,016
4,800 Added 29.32%
21,170 $2.46 Million
Q4 2022

Feb 08, 2023

SELL
$84.98 - $122.67 $408,753 - $590,042
-4,810 Reduced 22.71%
16,370 $1.85 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $995,603 - $1.23 Million
13,040 Added 160.2%
21,180 $1.71 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $94,098 - $183,919
1,384 Added 20.49%
8,140 $607,000
Q1 2022

May 13, 2022

BUY
$94.08 - $130.2 $169,344 - $234,359
1,800 Added 36.32%
6,756 $3.46 Million
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $77,922 - $97,692
-600 Reduced 10.8%
4,956 $2.66 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $183,541 - $246,269
1,720 Added 44.84%
5,556 $3.04 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $77,750 - $103,612
960 Added 33.38%
3,836 $1.64 Million
Q4 2020

Feb 12, 2021

SELL
$78.0 - $104.5 $96,330 - $129,057
-1,235 Reduced 30.04%
2,876 $4.25 Million
Q3 2020

Nov 16, 2020

BUY
$95.51 - $112.95 $859 - $1,016
9 Added 0.22%
4,111 $1.69 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $18,302 - $30,759
292 Added 7.66%
4,102 $1.66 Million
Q1 2020

May 15, 2020

BUY
$47.79 - $75.63 $71,685 - $113,445
1,500 Added 64.94%
3,810 $1.03 Million
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $84,592 - $132,339
2,310 New
2,310 $505,000
Q1 2019

May 15, 2019

SELL
$28.07 - $38.18 $35,929 - $48,870
-1,280 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$26.99 - $37.37 $34,547 - $47,833
1,280 New
1,280 $153,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Pier 88 Investment Partners LLC Portfolio

Follow Pier 88 Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.